Bauer HM, Hannah P, Moore D, Wolfe J, Knapp J, Trees D, Wang S,
Bolan G. Molecular epidemiology of quinolone-resistant Neisseria
gonoeehoeae in California, 2000-2002. [Abstract 283] 15th
Biennial Congress of the International Society for Sexually Transmitted
Diseases Research, Ottawa, Canada, July 27-30, 2003.
Conner SM, Wang SA, Weinstock HS. Ciprofloxacin resistant
gonorrhea within the continental United States, 1991-2000 [Abstract]. 2002
National STD Prevention Conference, San Diego, CA. March 4-7,
2002.
Fox KK, del Rio C, Holmes KK, Hook EW, Judson FN, Knapp JS, Procop
GW, Wang SA, Whittington WL, Levine WC. Gonorrhea in the HIV
Era: A Reversal in Trends Among Men Who Have Sex With Men. American
Journal of Public Health. 2001;91:959-964.
Fox KK, Knapp JS, Homes KK, Hook EW, Judson FN, Thompson SE, Washington
JA, Whittington WL. Antimicrobial Resistance in Neisseria
gonorrhoeae in the United States, 1988-1994: The Emergence of
Decreased Susceptibility to the Fluoroquinolones. Journal
of Infectious Disease. 1997;175:1396-1403.
Iverson CJ, Wang SA, Ohye R, Lee V, Domen H, Neal S, Trees D, Whiticar
P, Effler P. Emergence of a possible endemic focus of ciprofloxacin-resistant Neisseria
gonorrhoeae in Hawaii. [Abstract] Second International
Conference on Emerging Infectious Diseases, Atlanta, GA.July
16-19, 2000.
Johnson SR, Sandul AL, Parekh M, Wang SA, Knapp JS, Trees DL. Mutations
causing in vitro resistance to azithromycin in Neisseria gonorrhoeae. International
Journal of Antimicrobial Agents. 2003;21:414-419.
Katz AR, Lee MV, Ohye RG, Whiticar PM, Effler PV. Ciprofloxacin
resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002. The
Lancet. 2003;362(9382):495.
Knapp JS, Fox KK, Trees DL, Whittington WL. Fluoroquinolone
Resistance in Neisseria gonorrhoeae.Emerging
Infectious Diseases. 1997;3:33-39.
Mark KE, Bauer HM, Gunn RA, Wang SA, Knapp JS, Moore DS, Weismuller
P, Klausner JD, De Augustine N, Bolan G, and the California Resistance
Working Group. Increase in fluoroquinolone-resistant Neisseria
gonorrhoea- California, 2001 [Abstract 21]. 40th Annual
Meeting of the Infectious Diseases Society of America, Chicago, Illinois,
October 24-27, 2002.
McLean CA, Wang SA, Hoff G, Dennis L, Neal S, Knapp J, Markowitz
L, Levine WC. Emergence of Neisseria gonorrhoeae with
decreased susceptibility to azithromycin associated with commercial
sex in Kansas City, Missouri, 1999. [Abstract 543] 38th Annual
Meeting of the Infectious Diseases Society of America, New Orleans,
LA. September 7-10, 2000.
McLean CA, Wang SA, Hoff GL, Dennis LY, Trees DL, Knapp JS, Markowitz
LE, Levine WC. The emergence of Neisseria gonorrhoeae with
decreased susceptibility to azithromycin in Kansas City, Missouri,
1999-2000. Sexually Transmitted Diseases 2004;31:73-78.
Newman LM, Wang, SA, Ohye RG, Lee MV, Weinstock, HS. The epidemiology
of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii,
2001. Clinical Infectious Diseases 2004;38:649-654.
Newman LM, Wang SA, Weinstock HS. Emergence of ciprofloxacin-resistant Neisseria
gonorrhoea prevalence and risk factors for infection- United
States, 1998-2000 [Abstract 651]. 40th Annual Meeting of
the Infectious Diseases Society of America, Chicago, Illinois,
October 24-27, 2002.
Roy K, Wang S, Meltzer M. Identifying the optimal diagnostic
and treatment strategy for gonorrhea in a time of increasing ciprofloxacin-resistance
[Abstract]. 2002 National Foundation for Infectious Diseases
Conference on Antimicrobial Resistance, Bethesda, Maryland, June
27-29, 2002.
Schwarcz SK, Zenilman JM, Schnell D, Knapp JS, Hook EW, Thompson
S, Judson FN, Holmes KK. National Surveillance of Antimicrobial
Resistance in Neisseria gonorrhoeae. JAMA. 1990;264:1413-1417.
Wang SA. The continuing saga of gonococcal resistance : current
epidemiology and challenges. 2002 National Foundation for Infectious
Diseases Conference on Antimicrobial Resistance, Bethesda, Maryland,
June 29, 2002.
Wang SA, Harvey AB, Conner SM, Weinstock HS. Gonococcal susceptibility
and epidemiological trends: data from the Gonococcal Isolate Surveillance
Project, United States, 2002. [Abstract 284] 15th Biennial
Congress of the International Society for Sexually Transmitted Diseases
Research, Ottawa, Canada, July 27-30, 2003.
Wang SA, Harvey AB, Conner SM, Weinstock HS, and the Gonococcal
Isolate Surveillance Project Investigators. Trends in gonococcal
susceptibility and epidemiology in the United States for 2002 identified
through the Gonococcal Isolate Surveillance Project. [Abstract
924]. 41st Annual Meeting of the Infectious Diseases Society
of America, San Diego, California, October 9-10, 2003.
Wang SA, Harvey AB, Weinstock HS. Antimicrobial susceptibilities
of Neisseria gonorrhoeae in the United States [Abstract
401]. Thirteenth International Pathogenic Neisseria Conference
, Olso, Norway, September 1-6, 2002.
Wang SA, Lee MV, Iverson CJ, O'Connor N, Ohye RG, Hale JA, Knapp
JS, Effler PV, Weinstock HS. Multi-drug resistant Neisseria gonorrhoeae with
decreased susceptibility to cefixime, Hawaii 2001. [Abstract] International
Conference on Emerging Infectious Diseases, Atlanta, Georgia. March
25, 2002.
Wang SA, Lee MVC, Norman O'Connor N, Iverson CJ, Ohye RG, Whiticar
PM, Hale JA, Trees DL, Knapp JS, Effler PV, Weinstock HS. Multi-drug
resistant Neisseria gonorrhoeae with decreased susceptibility
to cefixime, Hawaii, 2001. Clinical Infectious Diseases 2003;37:849-52
Wang SA, Lee MVC, O'Connor N, Iverson CJ, Ohye RG, Whiticar PM,
Hale JA, Trees DL, Knapp JS, Effler PV, and Weinstock HS. Multidrug-resistant Neisseria
gonorrhoeae with decreased susceptibility to cefixime -- Hawaii,
2001. Clinical Infectious Diseases 2003;37:849-52
Other Relevant Publications and Abstracts
Akasaka S, Muratani T, Kobayashi T, Yamada Y, Inatomi H, Takahashi
K, Matsumoto T. Gonococcal urethritis and cervicitis caused
by CZRNG (cefozopran-resistant Neisseria gonorrhoeae)- clinical
failure cases treated with expanded spectrum cephems, fluoroquinolones
and minocycline [Abstract]. Thirteenth International Pathogenic
Neisseria Conference, Norwegian Institute of Public Health, Olso,
Norway. September 1-6, 2002.
Bala M, Ray K, Kumari S. Alarming increase in ciprofloxacin-
and penicillin-resistant Neisseria gonorrhoeae isolates
in New Delhi, India. Sexually Transmitted Diseases. 2003
Jun; 30(6):523-5.
Dan M, Poch F, Sheinberg B. High prevalence
of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in
Tel Aviv, Israel: Correlation with response to therapy. Antimicrobial
Agents and Chemotherapy. 2002 Jun;46(6):1671-3.
Dan M, Poch F, Shpitz D, and Sheinberg B. High-level ciprofloxacin
resistance in Neisseria gonorrhoeae: First report from Israel. Emerging
Infectious Diseases. 2001;7(1):1-2.
Etkind P, Ratelle S, and George H. International travel and
sexually transmitted disease. Emerging Infectious Diseases.
[Letter] 2003;9(12):654-1656.
Fenton KA, Ison C, Johnson AP, Rudd E, Soltani M, Martin I, Nichols
T, Livermore DM. Ciprofloxacin resistance in Neisseria
gonorrhoeae in England and Wales in 2002. The Lancet. 2003;361:1867-1869.
Forsyth A, Moyes A, Young H. Increased resistance in gonococci
isolated from Scotland. The Lancet. 2000;356:1984-85.
Goulet V, Sednaoui P, Laporte A, Billy C, Desenclos JC. The number
of gonococcal infections identified by the RENAGO network is increasing. Eurosurveillance
Monthly. 2000 January;5(1):2-5.
Hoffman, S. The laboratory surveillance system of Chlamydia
trachomatis and Neisseria gonorrhoeae infections
in Denmark. Eurosurveillance Monthly. 2001
May;6(5):86-90.
Mavroidi A, Tzouvelekis LS, Tassios PT, Flemetakis A, Daniilidou
M, and Tzelepi E. Characterization of Neisseria gonorrhoeae Strains
with Decreased Susceptibility to Fluoroquinolones Isolated in Greece
from 1996 to 1999. Journal of Clinical Microbiology. 2000;38:3489-3491
Muratani T, Kobayashi T, Yamada Y, Akasaka S, Inatomi H, Takahashi
K, Matsumoto T. Prevalence of super multi-drug resistant Neisseria
gonorrhoeae CZRNG (cefozopran-resistant N. gonorrhoeae)
in Japan. Thirteenth International Pathogenic Neisseria Conference,
Norwegian Institute of Public Health, Olso, Norway. September
1-6, 2002.
Rudd E and Fenton K. Large increase in ciprofloxacin resistant
gonorrhoea in England and Wales. Eurosurveillance Weekly. 2003
April;7(16).
Young H. Epidemiology and treatment outcome of infection
with antibiotic resistant strains of Neisseria gonorrhoeae in Scotland. Communicable
Disease and Public Health. 1999 Sept;2(3):198-202.